Back to company

NORDIC PHARMACEUTICALS ApS: Financial statements 2020

CVR: 27430015

NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 602,014 and a net result of DKK 57,931 compared with DKK 25,941 the year before. That is a decrease of 52.5% compared with the year before. Equity amounted to DKK 1,347,369. The solvency ratio was 65.3%. The company had 3 employees in the financial year.

Gross Profit
602,014 kr.
Profit/Loss
57,931 kr.
Equity
1,347,369 kr.
Total Assets
2,062,115 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-602 t.58 t.1.3 mio.3
2019-1.3 mio.26 t.1.3 mio.3
2018-1.1 mio.34 t.1.3 mio.3
2017-1 mio.40 t.1.2 mio.3
2016-1.4 mio.145 t.1.2 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NORDIC PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

NORDIC PHARMACEUTICALS ApS: The 2019 annual report is outAug 30, 2020

NORDIC PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 1,268,578, and the net result was DKK 25,941.

About NORDIC PHARMACEUTICALS ApS

NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 3 employees. In 2024, the company reported a gross profit of DKK -2,243,265 and a net result of DKK -2,664,416 compared with DKK 9,351 the year before. Equity amounted to DKK -1,152,541.